The financial terms of the deal were not disclosed in the Oct. 1 announcement. VSI provides portable vessel models that enable doctors to manipulate real medical devices within a physical 3D structure that replicates the human body’s vessel structure.
Gothenburg, Sweden–based Mentice, which has its U.S. headquarters in Chicago, said the acquisition will allow its clients to deploy and test real medical devices in a physical model under X-ray guidance, benefiting from a virtual high fidelity version of the same medical device and anatomy in a radiation-free environment.
“The combined product portfolio will allow Mentice to offer simulation solutions into every stage of a medical device’s development cycle helping improve speed to market, device adoption, and volume targets ultimately driving better patient outcomes,” said Dr. David Fiorella, VSI’s CMO and director of the Stony Brook Cerebrovascular Center and co-director of the Stony Brook Cerebrovascular and Comprehensive Stroke Center.
Mentice CEO Göran Malmberg described the combination of the two companies’ technologies as an exciting next step.
This acquisition gets us a step closer to fulfilling our mission of providing complete performance solutions to the field of endovascular therapies,” Malmberg said. “For more than 20 years, we have been pushing the envelope of simulation realism within this area and we will continue to raise the bar in technology innovation with solutions that ultimately make a difference one patient at a time.”